Evofosfamide clinical trials

Clinical Trial to Test Efficacy of Targeting Hypoxia Combined With ARSI After First-line ARSI Therapy for Castrate Resistant Prostate Cancer

This study is testing a new drug called evofosfamide alongside a standard prostate cancer treatment (ARSI) for men whose prostate cancer has spread and is no longer responding to initial hormone therapy. It aims to see if this new combination works better.